Monday, March 3rd, 2008
International Stem Cell Corporation (OTCBB:ISCO) announced that its human parthenogenetic stem cell lines will be used in Germany in studies aimed at creating specific cell types to treat human neural diseases such as Parkinson's disease.
The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany ...
Posted in Parkinson's Disease | No Comments »
Monday, March 3rd, 2008
Every minute, 30,000 of our outermost skin cells die so that we can live. When they do, new cells migrate from the inner layer of the skin to the surface of it, where they form a tough protective barrier. In a series of elegant experiments in mice, researchers at Rockefeller ...
Posted in Dermatology | No Comments »
Thursday, February 28th, 2008
PrimeGen Biotech announced that company researchers have successfully used purified proteins and DNAs in non-viral methods to reprogram adult human cells into stem cells.
Participating in this week's Stem Cell Summit in New York, the company reported that this new class of stem cells -- derived from adult human tissues such ...
Posted in Stem Cell Research | No Comments »
Monday, February 25th, 2008
The view into the inner world of living cells just got a little brighter and more colorful. A powerful new research tool, when used with other labeling technologies, allows simultaneous visualization of two or more different proteins as well as the ability to distinguish young and old copies of a ...
Posted in Biology / Biochemistry | No Comments »
Monday, February 25th, 2008
Advanced Cell Technology, Inc. (OTCBB: ACTC) reported for the first time a robust and highly efficient process for the generation of high-purity hepatocytes (liver cells). The research, described online (ahead of print) in the journal STEM CELLS, signifies a significant step towards the efficient generation of hepatocytes for use in ...
Posted in Stem Cell Research | No Comments »
Thursday, February 21st, 2008
Scientists at a US biotechnology company implanted immature beta-cells derived from human embryonic stem cells (hES cells) into mice and showed that they generated insulin-secreting cells that responded to raised blood sugar. They hope the discovery will one day lead to a renewable source of insulin-producing cells for the treatment ...
Posted in Diabetes | No Comments »
Wednesday, February 20th, 2008
A new gene therapy approach that attracts and "trains" immune system cells to destroy deadly brain cancer cells also provides long-term immunity, produces no significant adverse effects and -- in the process of destroying the tumor -- promotes the return of normal brain function and behavioral skills, according to a ...
Posted in Neurology / Neuroscience | No Comments »
Wednesday, February 20th, 2008
Neural cells derived from human embryonic stem cells helped repair stroke-related damage in the brains of rats and led to improvements in their physical abilities, according to a new study by researchers at the Stanford University School of Medicine.
This study, to be published in the Feb. 20 issue of the ...
Posted in Stroke / Neuroprotection | No Comments »
Wednesday, February 20th, 2008
Tumors require a blood supply to grow, but how they acquire their network of blood vessels is poorly understood. A new study here shows that tumor blood vessels can develop from precancerous stem cells, a recently discovered type of cell that can either remain benign or become malignant.
Researchers say the ...
Posted in Cancer / Oncology | No Comments »
